Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 14
Submit an article Journal homepage
262
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Using risperidone for Alzheimer's dementia-associated psychosis

Karleen M McNeal Alzheimer's Research and Clinical Programs, VA Medical Center and Medical University of South Carolina, Geriatrics and Extended Care, Charleston, SC, 29406-6076, USA +1 843 577 5011; +1 843 508 5957; [email protected]
,
Renee P Meyer Alzheimer's Research and Clinical Programs, VA Medical Center and Medical University of South Carolina, Geriatrics and Extended Care, Charleston, SC, 29406-6076, USA +1 843 577 5011; +1 843 508 5957; [email protected]
,
Karen Lukacs Alzheimer's Research and Clinical Programs, VA Medical Center and Medical University of South Carolina, Geriatrics and Extended Care, Charleston, SC, 29406-6076, USA +1 843 577 5011; +1 843 508 5957; [email protected]
,
Anna Senseney Alzheimer's Research and Clinical Programs, VA Medical Center and Medical University of South Carolina, Geriatrics and Extended Care, Charleston, SC, 29406-6076, USA +1 843 577 5011; +1 843 508 5957; [email protected]
&
Jacob Mintzer Alzheimer's Research and Clinical Programs, VA Medical Center and Medical University of South Carolina, Geriatrics and Extended Care, Charleston, SC, 29406-6076, USA +1 843 577 5011; +1 843 508 5957; [email protected]
Pages 2537-2543 | Published online: 08 Sep 2008

Bibliography

  • Hansberry MR, Chen E, Gorbien MJ. Dementia and elder abuse. Clin Geriatr Med 2005;21:315-32
  • Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-22
  • Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-71
  • Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000;8:29-34
  • White KE, Cummings JL. Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies. Compr Psychiatry 1996;37(3):188-95
  • Tran M, Bedard M, Molloy DW, et al. Associations between psychotic symptoms and dependence in activities of daily living among older adults with Alzheimer's disease. Int Psychogeriatr 2003;15:171-9
  • Paulsen JS, Salmon DP, Thal LJ, et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 2000;54:1965-71
  • Chan WC, Lam LC, Choy CN, et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 2001;16:1156-62
  • De Deyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999;53:946-55
  • Tariot PN. The older patient: the ongoing challenge of efficacy and tolerability. J Clin Psychiatry 1999;60(Suppl 23):29-33
  • Masand PS. Side effects of antipsychotics in the elderly. J Clin Psychiatry 2000;61(Suppl 8):43-9; discussion 50-1
  • Pharmaceuticals OM-J. Risperdal: full US prescribing information; 2008
  • Mintzer JE. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease. J Clin Psychiatry 2001;62(Suppl 21):23-5
  • Gorman DG, Read S, Cummings JL. Cholinergic therapy of behavioral disturbance in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:229-34
  • Byerly MJ, Weber MT, Brooks DL, et al. Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs Aging 2001;18:45-61
  • Katz IR, Jeste DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999;60:107-15
  • Coccaro EF, Siever LJ, Klar HM, et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 1989;46:587-99
  • Mintzer J, Brawman-Mintzer O, Mirski DF, et al. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry 1998;44:918-21
  • Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother 2000;1:1441-53
  • Brodaty H, Ames D, Snowdon J, et al. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 2003;64:134-43
  • Suh GH, Son HG, Ju YS, et al. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances. Am J Geriatr Psychiatry 2004;12:509-16
  • Mintzer J, Greenspan A, Caers I, et al. Risperidone in the treatment of psychosis of Alzheimer disease: results from a prospective clinical trial. Am J Geriatr Psychiatry 2006;14:280-91
  • Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med 2006;355:1525-38
  • Cooper JW. Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J 1999;92:485-90
  • Madhusoodanan S, Suresh P, Brenner R, Pillai R. Experience with the atypical antipsychotics–risperidone and olanzapine in the elderly. Ann Clin Psychiatry 1999;11:113-8
  • Zarate CA Jr, Baldessarini RJ, Siegel AJ, et al. Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry 1997;58:311-7
  • Davidson M, Harvey PD, Vervarcke J, et al. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group. Int J Geriatr Psychiatry 2000;15:506-14
  • Kleinberg DL, Davis JM, de Coster R, et al. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999;19:57-61
  • Advisory FPH. United States Food and Drug Administration. Deaths with antipsychotics in elderly patients with behavioral disturbances; 2005
  • Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43
  • Atypical antipsychotics in the elderly. Med Lett Drugs Ther 2005;47:61-2
  • Aupperle P. Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics. Am J Alzheimers Dis Other Demen 2006;21:101-8
  • Baker W. Relative frequencies of Alzheimer disease, lewy body, vascular and frontotemporal dementia, hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis Assoc Disord 2002;16:203-12
  • Barrett J. Knowledge about Alzheimer's disease among primary care physicians, psychologists, nurses and social workers. Alzheimer Dis Assoc Disord 1997;2:99-106
  • Conley, RR. Risperidone side effects. J Clin Psychiatry 2000;61(Suppl 8):20-3
  • Devanand DP, Marder K, Michaels KS, et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 1998;155:1512-9
  • Doraiswamy P. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol 2002;57:173-7
  • Goldberg RJ, Goldberg J. Risperidone for dementia related disturbed behavior in nursing home residents: a clinical experience. Int Psychogeriatr 1997;9:65-8
  • Jeste DV, Okamoto A, Napolitano J, et al. Low incidence of persistent tardive dyskinesia in elderly patients with dementia treated with risperidone. Am J Psychiatry 2000;157:1150-5
  • Kasper S, Muller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 2000;1:783-801
  • Laughren T. A regulatory perspective on psychiatric syndromes in Alzheimer's disease. Am Assoc Geriatr Psychiatry 2001;9:340-5
  • Mintzer J. What are the challenges faced by psychiatrists in the management of Alzheimer's disease? CNS Spectr 2004;9:13-5
  • Mittelman M. A family intervention to delay nursing home placement of patients with Alzheimer disease. JAMA 1996;276:1725-8
  • Palmer AM, Stratmann GC, Proctor AW, Bowen DM. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann Neurol 1988;23:616-20
  • Reisberg B, Auer SR, Monteiro IM. Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int Psychogeriat 1996;8:301-8
  • Suh GH, Son HG, Ju YS, et al. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances. Am J Geriatr Psychiatry 2004;12:509-16
  • Wadley V. Diagnostic attributions versus labeling: impact of Alzheimer's disease and major depression diagnoses on emotions, beliefs and helping intentions of family members. J Gerontol 2001;56:244-52
  • Zaleon CR, Guthrie SK. Antipsychotic drug use in older adults. Am J Hosp Pharm 1994;51:17-43
  • Schneider LS, Katz IR, Park S, et al. Psychosis of Alzheimer disease: validity of the construct and response to risperidone. Am J Geriatr Psychiatry 2003;11:414-25
  • Chui HC, Lyness SA, Sobel E, Schneider LS. Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Arch Neurol 1994;51:676-81
  • Feil N. The validation breakthrough: simple techniques for communication with people with Alzheimer's-type dementia. Baltimore: Health Professions Press; 1991
  • Clark L. Interventions for persons with Alzheimer's disease: strategies for maintaining and enhancing communicative success. Top Lang 1995;15:47-65

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.